Back to today’s briefing

Story perspectives

Breakthrough RLT Approved for Advanced Prostate Cancer Treatment

10/6/2025

32 6 Full Breakdown

Summary

Story summary

RLT is approved for metastatic castration-resistant prostate cancer (CRPC) and may expand to genitourinary cancers, Praful Ravi says.
The PSMAddition trial seeks to test RLT earlier in treatment without hormone therapy.
Researchers are testing RLT in combination with chemotherapy and other therapies to improve outcomes.
PSMA-PET (prostate-specific membrane antigen) scans are standard before and during therapy.

1 of 1

Story summary

RLT is approved for metastatic castration-resistant prostate cancer (CRPC) and may expand to genitourinary cancers, Praful Ravi says.
The PSMAddition trial seeks to test RLT earlier in treatment without hormone therapy.
Researchers are testing RLT in combination with chemotherapy and other therapies to improve outcomes.
PSMA-PET (prostate-specific membrane antigen) scans are standard before and during therapy.